| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer
1 company
Congleton Jon serves as a Chief Executive Officer at MLYS. Across recent SEC filings that breaks down to 4 buys and 23 sells. Those positions are worth an estimated $15.4M at current prices.
Historically, Congleton Jon's trades have earned a below-average insider score of 46/100 across 19 rated trades. Over a 12-month horizon, 6.7% of those trades were profitable, with an average 12-month return of -28.4%.
The biggest single holding is MLYS (~$15.4M) as Chief Executive Officer. The recent filings there lean toward selling, a net 449,679 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Sell | 49,313 | $12.01 | $592,022.00 | -1.7% | -0.2% | +15.1% | |
| Jun 14, 2024 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Sell | 72,797 | $12.70 | $924,203.22 | -2.4% | -7.9% | +13.8% | |
| Nov 22, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 4,250 | $5.97 | $25,355.93 | +0.4% | +156.7% | +99.2% | |
| Sep 6, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 2,250 | $12.08 | $27,180.00 | +0.2% | -43.9% | -1.5% | |
| Aug 17, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 2,250 | $12.10 | $27,225.00 | +0.2% | -44.3% | -19.5% | |
| Aug 11, 2023 | MLYS Mineralys Therapeutics, Inc. | Chief Executive Officer | Buy | 2,000 | $12.89 | $25,780.00 | +0.2% | -42.2% | -14.0% |